Immutep Reports Positive Final Data from the INSIGHT-004 Phase I Study of LAG-3 Therapy, Efti, at ASCO 2021

NEXT STORY
Akoya and AstraZeneca to Collaborate on Spatial Biology Approach to Profiling Tumor-Immune Biology
PREV STORY
The U.S. esoteric testing market size is expected to grow at a CAGR of around 7% during 2020-2026
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Merus Announces Poster Presentations on Zenocutuzumab and MCLA-158 at the AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics

author_avatar
NASDAQ Market News

Natera and Neon Therapeutics Announce Clinical Trial Collaboration to Assess Treatment Response to Personal Cancer Vaccine

Combines Neon’s Personal Neoantigen Vaccine and Signatera (RUO) Circulating Tumor DNA Biomarker in Metastatic ...

author_avatar
NASDAQ Market News

Summit’s Pipeline Expands with Series of New Mechanism Antibiotics Targeting Enterobacteriaceae

author_avatar
NASDAQ Market News